Press Release

Incyte to Present at Upcoming Investor Conference

WILMINGTON, Del.--(BUSINESS WIRE)--Aug. 28, 2018-- Incyte Corporation (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 16th Annual Global Healthcare Conference on Thursday, September 13, 2018 at 10:00 am EDT in New York.

The presentation and Q&A session will be webcast live and can be accessed at in the Investors section under “Events and Presentations.” Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at

Follow @Incyte on Twitter at

Source: Incyte Corporation

Incyte Corporation
Catalina Loveman, +1 302-498-6171
Michael Booth, DPhil, +1 302-498-5914